Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Context Therapeutics

Recent news which mentions Context Therapeutics

Context Therapeutics CEO Marty Lehr notes progress towards the clinic with CTIM-76 in 2Q update
Tickers CNTX
Tags Context Therapeutics XNAS:CNTX
From TheNewswire.com - RSS (Media)
Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update
Tags XNAS:CNTX Context Therapeutics
From TheNewswire.com - RSS (Media)
ASCO 2023 – Claudin 6 Makes A Splash In Ovarian Cancer
Tickers AMGN BNTX CNTX
Tags AMGN Benzinga Penny Stocks
From Benzinga
Context Therapeutics CTIM-76 bispecific antibody preclinical data presented at AACR Annual Meeting
Tags Context Therapeutics XNAS:CNTX
From TheNewswire.com - RSS (Media)
Significant Unmet Need In Solid Tumors Reported, And How Context Therapeutics (NASDAQ: CNTX) Plans To Make A Difference
Tickers CNTX
Tags Penny Stocks CNTX Benzinga
From Benzinga
Lab Notes: Center for Breakthrough Medicines expands offerings; Researchers identify key 'gene signature'
Tickers INNO
Tags J/C/ Simeon Maureen Murphy Medical Devices
From Business Journals
Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapy
Tickers INNO
Tags Roundup Pharmaceuticals NexGel
From Business Journals
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
Tags XNAS:CNTX Context Therapeutics
From TheNewswire.com - RSS (Media)
Context Therapeutics Partners With Integral Molecular To Develop An Emerging Cancer Drug
Tickers CNTX
Tags Context Therapeutics Biotech Market News
From Benzinga
New Ammo In The Battle Against Cancer – Context Therapeutics Sees Promising Results For Several Novel Drugs
Tickers CNTX
Tags Partner Content Interview Context Therapeutics
From Benzinga
Lab Notes: Wistar Institute gets $5M NCI grant extension; Aclaris expands management team
Tickers INNO
Tags Inno Context Therapeutics Biotech
From Business Journals
Lab Notes: Oncora Medical doubles its client base; Context Therapeutics posts promising cancer drug data
Tickers INNO
Tags Context Therapeutics Inno Biotech
From Business Journals
What About Women? This Company Targets Female-Focused Cancers
Tickers CNTX
Tags General CNTX Benzinga
From Benzinga
Context Therapeutics raises $31M in fresh funding from stock sale
Tags Martin Lehr Pharmaceuticals Felix Kim
From Business Journals
Lab Notes: CHOP-based brain tumor network gets NIH boost; Integral Molecular inks deal with Astrazeneca
Tickers INNO
Tags Antony Koblish Health Care Jennifer Minai/Azary
From Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
Tickers INNO
Tags Context Therapeutics Inno Biotech
From Business Journals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.